ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENT
The incidence of upper respiratory tract acute pathologies is quite high and is 6.8 per 1,000 population in the autumn and winter period. According to the World Health Organization in Europe acute rhinosinusitis occur every seventh person per year, the disease is diagnosed in 16% of adults in the U...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-05-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1840 |
| _version_ | 1797841667387031552 |
|---|---|
| author | P. A. Kochetkov E. I. Fatyanova |
| author_facet | P. A. Kochetkov E. I. Fatyanova |
| author_sort | P. A. Kochetkov |
| collection | DOAJ |
| description | The incidence of upper respiratory tract acute pathologies is quite high and is 6.8 per 1,000 population in the autumn and winter period. According to the World Health Organization in Europe acute rhinosinusitis occur every seventh person per year, the disease is diagnosed in 16% of adults in the United States. There are 10000000 registered cases of acute rhinosinusitis each year in Russian Federation.In recent years, acute sinusitis treatment, in addition to traditional antibacterial, anti-inflammatory, much attention is paid mucolytic drugs . Since 1994, new mucolytic drug sinupret has been registered for acute sinusitis treatment.Analysis of the literature suggests that Sinupret regulates the secretion and normalizes the viscosity of mucus; eliminates mukostasis; It acts on the mucous membrane decongestants and anti-inflammatory; restores drainage and ventilation of the paranasal sinuses; normalizes the protective function of the airway epithelium against endogenous and exogenous damaging factors; It interrupts the vicious circle in inflammation of paranasal sinuses; antibiotic therapy improves the results.Thus Sinupret drug can be recommended for the treatment of acute sinusitis in clinical practice. A number of clinical trials have shown high efficacy, safety and convenience advantage of the drug in treating this highly prevalent and socially significant diseases. |
| first_indexed | 2024-04-09T16:35:01Z |
| format | Article |
| id | doaj.art-f3cf3c7ebe694f669932be4ee6f624b9 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:35:01Z |
| publishDate | 2017-05-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-f3cf3c7ebe694f669932be4ee6f624b92023-04-23T06:56:56ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-05-010813013610.21518/2079-701X-2017-8-130-1361818ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENTP. A. Kochetkov0E. I. Fatyanova1First MSMU. THEM. SechenovFirst MSMU. THEM. SechenovThe incidence of upper respiratory tract acute pathologies is quite high and is 6.8 per 1,000 population in the autumn and winter period. According to the World Health Organization in Europe acute rhinosinusitis occur every seventh person per year, the disease is diagnosed in 16% of adults in the United States. There are 10000000 registered cases of acute rhinosinusitis each year in Russian Federation.In recent years, acute sinusitis treatment, in addition to traditional antibacterial, anti-inflammatory, much attention is paid mucolytic drugs . Since 1994, new mucolytic drug sinupret has been registered for acute sinusitis treatment.Analysis of the literature suggests that Sinupret regulates the secretion and normalizes the viscosity of mucus; eliminates mukostasis; It acts on the mucous membrane decongestants and anti-inflammatory; restores drainage and ventilation of the paranasal sinuses; normalizes the protective function of the airway epithelium against endogenous and exogenous damaging factors; It interrupts the vicious circle in inflammation of paranasal sinuses; antibiotic therapy improves the results.Thus Sinupret drug can be recommended for the treatment of acute sinusitis in clinical practice. A number of clinical trials have shown high efficacy, safety and convenience advantage of the drug in treating this highly prevalent and socially significant diseases.https://www.med-sovet.pro/jour/article/view/1840acute rhynosinusitisacute rhynosinusitis treatmentacute rhynosinusitis treatment without surgerysinus surgeryadhatoda vasicalife qualityevidence based medicine |
| spellingShingle | P. A. Kochetkov E. I. Fatyanova ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENT Медицинский совет acute rhynosinusitis acute rhynosinusitis treatment acute rhynosinusitis treatment without surgery sinus surgery adhatoda vasica life quality evidence based medicine |
| title | ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENT |
| title_full | ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENT |
| title_fullStr | ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENT |
| title_full_unstemmed | ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENT |
| title_short | ACUTE RHINOSINUSITIS: ACTUAL APPROACHES TO DIAGNOSIS AND TREATMENT |
| title_sort | acute rhinosinusitis actual approaches to diagnosis and treatment |
| topic | acute rhynosinusitis acute rhynosinusitis treatment acute rhynosinusitis treatment without surgery sinus surgery adhatoda vasica life quality evidence based medicine |
| url | https://www.med-sovet.pro/jour/article/view/1840 |
| work_keys_str_mv | AT pakochetkov acuterhinosinusitisactualapproachestodiagnosisandtreatment AT eifatyanova acuterhinosinusitisactualapproachestodiagnosisandtreatment |